Eisai

-5.62%

Eisai Co., Ltd. is a global pharmaceutical company headquartered in Japan. Founded in 1941, the company focuses on developing, manufacturing, and marketing innovative medicines in several therapeutic areas, including neurology, oncology, and critical care.
Eisai is committed to improving the lives of patients and their families by addressing unmet medical needs and supporting the healthcare system. The company's product portfolio includes treatments for Alzheimer's disease, epilepsy, cancer, and other diseases.
With a presence in over 55 countries, Eisai has a global network of research and development, manufacturing, and marketing facilities. The company collaborates with partners around the world to expand its reach and bring its medicines to those in need.
In addition to its work in developing and commercializing medicines, Eisai also prioritizes corporate responsibility, sustainability, and diversity and inclusion initiatives. The company values the voice of patients and strives to put their interests at the center of everything it does.
Overall, Eisai is committed to making a positive impact on the global healthcare landscape and helping to enhance the quality of life for patients and their families.

1. Founder's philosophy: The Eisai company was founded by a Buddhist monk, Dr. Shinobu Eisai, in 1941. He believed in the importance of "human health as the foundation of happiness" and the responsible role of a pharmaceutical company in society.
2. Focus on human health: The company's mission is to "give first thoughts to patients and their families." It prioritizes the needs of patients and aims to provide safe, effective, and affordable medicines.
3. Global presence: Eisai is a multinational company with operations in 55 countries and regions worldwide. It has a strong presence in Japan, the US, and Asia, but also has a growing business in Europe and developing countries.
4. Diverse product portfolio: The company's product portfolio includes a broad range of prescription drugs, over-the-counter medications, and medical devices in various therapeutic areas such as neurology, oncology, and gastrointestinal disorders.
5. Commitment to research and innovation: Eisai invests a significant portion of its revenues in research and development, with a focus on innovative treatments for unmet medical needs. It also collaborates with academic institutions, biotech companies, and other pharmaceutical companies to advance new therapies.
6. Patient support programs: The company offers several patient support programs, such as medication assistance and education programs, to help patients access and understand their medicines.
7. Social and environmental responsibility: Eisai is committed to promoting sustainable practices and environmental conservation. It also supports various social initiatives, such as disaster relief efforts and healthcare access in developing countries.
8. Awards and recognition: The company has received recognition for its efforts in various areas, including patient advocacy, research and development, and corporate social responsibility. Most notably, Eisai was named the most innovative Japanese pharmaceutical company in 2020 by the Forbes Global 2000 list.
9. Corporate culture: The company promotes a supportive and collaborative corporate culture, emphasizing diversity, inclusion, and work-life balance for its employees.
10. Strong financial performance: Eisai has a strong financial track record, with steady revenue growth and profitability. This allows the company to continue investing in research and development and expanding its global presence to serve more patients.